How China’s Leading Female Healthcare Investor Backs Billion-Dollar Biotech Companies

  • 📰 Forbes
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 53%

México Noticias Noticias

México Últimas Noticias,México Titulares

As managing partner of Qiming Venture Partners, Nisa Leung has invested in over 30 of China’s healthcare giants. Underlying her prolific track record is her goal to solve as many incurable diseases as possible.

’s Xiaomi. The investment firm has raised a total of $9.4 billion in capital across 11 funds, with a particular focus on the consumer tech and healthcare industries; sLast December, Chinese authoritiesthe relaxation of strict Covid-19 control measures in cities across China, spurring market rallies as investors bet the world’s second-largest economy would finally reopen to the rest of the world.

“It's really that perseverance, which I think is so important,” she says. Adapting to the severe “hardships” of lockdown required teams to have tremendous faith, accepting low or nonexistent salaries until they could resume their normal schedules. “That's why I always say ‘do not bet against Chinese entrepreneurs, because they work really, really hard,’” she adds.

Since then, Leung has overseen investment in China’s healthcare scene, introducing U.S.-based companies into the domestic market while nurturing homegrown talent. She’s tapped into burgeoning fields such as AI-powered drug discovery, which uses advanced algorithms to predict the movement of molecules and find those that work for specific diseases. One of her notable investments at Qiming is Schrödinger, which builds AI simulation software that helps scientists discover effective compounds.

 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 394. in MX

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

PacWest is among the leading gainers in pre-market on Q1 resultsPacWest Bancorp stock is up 13.5% as the top gainer in premarket trades, according to the MarketWatch Premarket Screener, after the bank posted first-quarter...
Fuente: MarketWatch - 🏆 3. / 97 Leer más »